131 related articles for article (PubMed ID: 26603927)
1. QSAR and Docking Studies of N-hydroxy Urea Derivatives as Flap Endonuclease-1 Inhibitors.
Wadhwa P; Jain P; Jadhav HR
Curr Comput Aided Drug Des; 2015; 11(4):346-52. PubMed ID: 26603927
[TBL] [Abstract][Full Text] [Related]
2. A study on quantitative structure-activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold.
Abbasi M; Ramezani F; Elyasi M; Sadeghi-Aliabadi H; Amanlou M
Daru; 2015 Apr; 23(1):29. PubMed ID: 25925871
[TBL] [Abstract][Full Text] [Related]
3. Modeling and Proposed Molecular Mechanism of Hydroxyurea Through Docking and Molecular Dynamic Simulation to Curtail the Action of Ribonucleotide Reductase.
Iman M; Khansefid Z; Davood A
Recent Pat Anticancer Drug Discov; 2016; 11(4):461-468. PubMed ID: 27670694
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Myricetin as a Potent Inhibitor of Human Flap Endonuclease 1, Which Potentially Can Be Used as Sensitizing Agent against HT-29 Human Colon Cancer Cells.
Ma L; Cao X; Wang H; Lu K; Wang Y; Tu C; Dai Y; Meng Y; Li Y; Yu P; Man S; Diao A
J Agric Food Chem; 2019 Feb; 67(6):1656-1665. PubMed ID: 30694659
[TBL] [Abstract][Full Text] [Related]
5. The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors.
Tumey LN; Bom D; Huck B; Gleason E; Wang J; Silver D; Brunden K; Boozer S; Rundlett S; Sherf B; Murphy S; Dent T; Leventhal C; Bailey A; Harrington J; Bennani YL
Bioorg Med Chem Lett; 2005 Jan; 15(2):277-81. PubMed ID: 15603939
[TBL] [Abstract][Full Text] [Related]
6. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
[TBL] [Abstract][Full Text] [Related]
7. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
8. Structure-based QSAR, molecule design and bioassays of protease-activated receptor 1 inhibitors.
Zhong W; Liu P; Zhang Q; Li D; Lin J
J Biomol Struct Dyn; 2017 Oct; 35(13):2853-2867. PubMed ID: 27809674
[TBL] [Abstract][Full Text] [Related]
9. Design of potential anti-tumor PARP-1 inhibitors by QSAR and molecular modeling studies.
Abbasi-Radmoghaddam Z; Riahi S; Gharaghani S; Mohammadi-Khanaposhtanai M
Mol Divers; 2021 Feb; 25(1):263-277. PubMed ID: 32140890
[TBL] [Abstract][Full Text] [Related]
10. Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site.
Exell JC; Thompson MJ; Finger LD; Shaw SJ; Debreczeni J; Ward TA; McWhirter C; Siöberg CL; Martinez Molina D; Abbott WM; Jones CD; Nissink JW; Durant ST; Grasby JA
Nat Chem Biol; 2016 Oct; 12(10):815-21. PubMed ID: 27526030
[TBL] [Abstract][Full Text] [Related]
11. Design of the influenza virus inhibitors targeting the PA endonuclease using 3D-QSAR modeling, side-chain hopping, and docking.
Yan Z; Zhang L; Fu H; Wang Z; Lin J
Bioorg Med Chem Lett; 2014 Jan; 24(2):539-47. PubMed ID: 24365156
[TBL] [Abstract][Full Text] [Related]
12. Development of linear and nonlinear predictive QSAR models and their external validation using molecular similarity principle for anti-HIV indolyl aryl sulfones.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2008 Dec; 23(6):980-95. PubMed ID: 18608761
[TBL] [Abstract][Full Text] [Related]
13. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
[TBL] [Abstract][Full Text] [Related]
14. Insights into the Structural Requirements of 2(S)-Amino-6-Boronohexanoic Acid Derivatives as Arginase I Inhibitors: 3D-QSAR, Docking, and Interaction Fingerprint Studies.
Velázquez-Libera JL; Navarro-Retamal C; Caballero J
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274146
[TBL] [Abstract][Full Text] [Related]
15. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
16. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
Fatemi MH; Heidari A; Gharaghani S
J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
[TBL] [Abstract][Full Text] [Related]
17. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
Gurung AB; Aguan K; Mitra S; Bhattacharjee A
J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
[TBL] [Abstract][Full Text] [Related]
18. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
Abbasi M; Sadeghi-Aliabadi H; Amanlou M
Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
[TBL] [Abstract][Full Text] [Related]
19. QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase IIα.
Alam S; Khan F
Drug Des Devel Ther; 2014; 8():183-95. PubMed ID: 24516330
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
Zeng H; Zhang H; Jang F; Zhao L; Zhang J
Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
